Literature DB >> 7852501

Gonadotropin-releasing hormone receptor gene expression in human ovary and granulosa-lutein cells.

D Minaretzis1, M Jakubowski, J F Mortola, S N Pavlou.   

Abstract

GnRH regulates gonadotropin biosynthesis and release in the anterior pituitary via specific receptors. Although extrapituitary expression and action of GnRH have been shown in some species, in the human it is not clear whether GnRH has a peripheral action. In this study we sought to determine whether the human ovary expresses GnRH receptor (GnRHR) messenger ribonucleic acid (mRNA). Ovarian tissues from 11 women (32-61 yr old) and granulosa-lutein (GL) cells purified from follicular aspirates of 51 women undergoing oocyte retrieval for in vitro fertilization were analyzed by ribonuclease protection assay and reverse transcriptase-polymerase chain reaction (RT-PCR). Human pituitaries, lymphocytes, and placenta were also studied. Measurable levels of GnRHR mRNA were found by ribonuclease protection assay in 2 of 10 ovaries, in 2 of 4 GL cells preparations from women whose ovarian hyperstimulation involved a GnRH agonist, in GL cells from 3 women whose ovarian hyperstimulation involved a GnRH antagonist, and in human pituitaries. Relative to the total amount of RNA analyzed, the level of GnRHR mRNA was about 200-fold lower in the ovary than in the pituitary. A sequence of 314 basepairs of GnRHR mRNA was amplified by RT-PCR in the pituitary, in 9 of 10 ovaries, and in 4 of 5 GL cell preparations. No message could be amplified in human lymphocytes, and placental specimens showed a weak signal. The relative GnRHR mRNA levels in GL cells from 13 women analyzed by quantitative RT-PCR showed a wide range of individual differences. These results suggest that GnRHR mRNA is expressed in GL cells and the human ovary across different functional stages, implying that multiple ovarian compartments may express GnRH receptors. The administration of GnRH analogs may have a further direct action on the human ovary.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7852501     DOI: 10.1210/jcem.80.2.7852501

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  19 in total

1.  Gonadotropin-releasing hormone messenger ribonucleic acid and protein expression in Vero cells.

Authors:  H Y Huang; F Raga; J S Kruessel; Y Wen; Y K Soong; M L Polan
Journal:  J Assist Reprod Genet       Date:  2001-05       Impact factor: 3.412

2.  GnRH antagonist administered twice the day before hCG trigger combined with a step-down protocol may prevent OHSS in IVF/ICSI antagonist cycles at risk for OHSS without affecting the reproductive outcomes: a prospective randomized control trial.

Authors:  Yannis Prapas; Konstantinos Ravanos; Stamatios Petousis; Yannis Panagiotidis; Achilleas Papatheodorou; Chrysoula Margioula-Siarkou; Assunta Iuliano; Giuseppe Gullo; Nikos Prapas
Journal:  J Assist Reprod Genet       Date:  2017-08-03       Impact factor: 3.412

3.  Association of inhibin B serum levels with parameters of follicular response in a randomized controlled trial comparing gnRH agonist versus antagonist protocols for ovarian hyperstimulation.

Authors:  Barbara Sonntag; Ludwig Kiesel; Eberhard Nieschlag; Hermann M Behre
Journal:  J Assist Reprod Genet       Date:  2004-07       Impact factor: 3.412

Review 4.  The role of aromatase inhibitors in ameliorating deleterious effects of ovarian stimulation on outcome of infertility treatment.

Authors:  Mohamed F M Mitwally; Robert F Casper; Michael P Diamond
Journal:  Reprod Biol Endocrinol       Date:  2005-10-04       Impact factor: 5.211

5.  Improvement of IVF outcome in poor responders by discontinuation of GnRH analogue during the gonadotropin stimulation phase--a function of improved embryo quality.

Authors:  M Schachter; S Friedler; A Raziel; D Strassburger; O Bern; R Ron-el
Journal:  J Assist Reprod Genet       Date:  2001-04       Impact factor: 3.412

6.  Subpopulations of human granulosa-luteal cells obtained from gonadotropin- or gonadotropin-releasing hormone agonist/gonadotropin-treated follicles in in vitro fertilization-embryo transfer cycles.

Authors:  K Gersak; T Tomazevic
Journal:  J Assist Reprod Genet       Date:  1999-10       Impact factor: 3.412

7.  Immunohistochemical localization of GnRH and RFamide-related peptide-3 in the ovaries of mice during the estrous cycle.

Authors:  Padmasana Singh; Amitabh Krishna; Rajagopala Sridaran; Kazuyoshi Tsutsui
Journal:  J Mol Histol       Date:  2011-07-19       Impact factor: 2.611

Review 8.  Depot versus daily administration of gonadotrophin-releasing hormone agonist protocols for pituitary down regulation in assisted reproduction cycles.

Authors:  Luiz Eduardo T Albuquerque; Leopoldo O Tso; Humberto Saconato; Maria Cecília R M Albuquerque; Cristiane R Macedo
Journal:  Cochrane Database Syst Rev       Date:  2013-01-31

9.  Analysis of implantation in assisted reproduction through the use of serial human chorionic gonadotropin measurements.

Authors:  M I Hsu; P Kolm; J Leete; K W Dong; S Muasher; S Oehninger
Journal:  J Assist Reprod Genet       Date:  1998-09       Impact factor: 3.412

10.  Expression of gonadotropin-releasing hormone receptor and effect of gonadotropin-releasing hormone analogue on proliferation of cultured gastric smooth muscle cells of rats.

Authors:  Lei Chen; Hong-Xuan He; Xu-De Sun; Jing Zhao; Li-Hong Liu; Wei-Quan Huang; Rong-Qing Zhang
Journal:  World J Gastroenterol       Date:  2004-06-15       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.